Brady Beltran

Summary

Publications

  1. ncbi EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
    Brady Beltran
    The Warren Alpert Medical School of Brown University, Division of Hematology and Oncology, The Miriam Hospital, Providence, RI, USA
    Infect Agent Cancer 4:10. 2009
  2. ncbi [Primary colorectal lymphoma of diffuse large B-cells: an experience at a general hospital]
    Brady Beltran Gárate
    Oncólogo médico, Departamento Oncología Médica Radioterapia, Hospital Edgardo Rebagliati Martins
    Rev Gastroenterol Peru 28:235-8. 2008
  3. ncbi ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature
    Brady Beltran
    Department of Oncology and Radiotherapy, Edgardo Rebagliati Martins Hospital, Lima, Peru
    J Hematol Oncol 2:11. 2009
  4. ncbi [Gastric adult T cell leukemia/lymphoma: report of four cases and review of literature]
    Brady Beltran
    Oncólogo médico del Departamento Oncología Radioterapia del Hospital Edgardo Rebagliati Martins, Lima, Peru
    Rev Gastroenterol Peru 30:153-7. 2010
  5. ncbi Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
    Domingo Morales
    Department of Pathology, Edgardo Rebagliati Martins Hospital, Lima, Peru
    Leuk Lymphoma 51:66-72. 2010
  6. ncbi Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma
    Brady Beltran
    Department of Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
    Leuk Res 35:334-9. 2011

Collaborators

  • Jorge J Castillo
  • Domingo Morales
  • Alejandro Yabar
  • Fernando Hurtado de Mendoza
  • Brady Beltran Gárate
  • Pilar Quinones
  • Luis Riva
  • James N Butera
  • Pilar Quiñones Avila
  • Domingo Morales Luna
  • Karem Portugal Meza
  • Luis Riva Gonzales

Detail Information

Publications6

  1. ncbi EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
    Brady Beltran
    The Warren Alpert Medical School of Brown University, Division of Hematology and Oncology, The Miriam Hospital, Providence, RI, USA
    Infect Agent Cancer 4:10. 2009
    ..Furthermore, the immunodeficiency caused by the viral infections and chemotherapy may have played a role in developing life-threatening infectious complications...
  2. ncbi [Primary colorectal lymphoma of diffuse large B-cells: an experience at a general hospital]
    Brady Beltran Gárate
    Oncólogo médico, Departamento Oncología Médica Radioterapia, Hospital Edgardo Rebagliati Martins
    Rev Gastroenterol Peru 28:235-8. 2008
    ..The 5-year survival per stage was 26, 11 and 5 months, respectively. Primary colorectal lymphoma of diffuse large B-cells usually affects the right part of the colon in an aggressive manner...
  3. ncbi ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature
    Brady Beltran
    Department of Oncology and Radiotherapy, Edgardo Rebagliati Martins Hospital, Lima, Peru
    J Hematol Oncol 2:11. 2009
    ..The latest WHO classification of lymphomas recognizes ALK-DLBCL as a separate entity...
  4. ncbi [Gastric adult T cell leukemia/lymphoma: report of four cases and review of literature]
    Brady Beltran
    Oncólogo médico del Departamento Oncología Radioterapia del Hospital Edgardo Rebagliati Martins, Lima, Peru
    Rev Gastroenterol Peru 30:153-7. 2010
    ..We report four cases with gastric involvement. We describe clinical and endoscopic findings of cases and review literature...
  5. ncbi Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
    Domingo Morales
    Department of Pathology, Edgardo Rebagliati Martins Hospital, Lima, Peru
    Leuk Lymphoma 51:66-72. 2010
    ..Our study supports EBV status as a powerful prognostic factor in de novo nodal DLBCL. Prospective studies should be carried to validate this hypothesis...
  6. ncbi Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma
    Brady Beltran
    Department of Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
    Leuk Res 35:334-9. 2011
    ..Adult T-cell leukemia/lymphoma (ATLL) is a clinically aggressive and heterogeneous entity; hence it is likely that different variants of ATLL have different prognostic factors...